ZNF532 is a zinc finger transcription factor involved in multiple pathological processes, particularly cancer development and progression. In NUT midline carcinoma (NMC), ZNF532 associates with the oncogenic BRD4-NUT fusion protein and participates in feed-forward regulatory loops that propagate oncogenic chr18 complexes 1. A rare ZNF532-NUTM1 fusion has been identified as a novel oncogenic driver in NUT carcinoma cases, creating hyperacetylated megadomains similar to those in BRD4-NUT patients 1. ZNF532 functions as a component of the "Z4" protein complex alongside ZNF592 and ZMYND8, with NUT carcinoma cells showing specific dependency on these Z4 factors 2. In laryngeal squamous cell carcinoma, ZNF532 acts downstream of FOXD1 transcriptional activation to promote epithelial-to-mesenchymal transition and cellular invasion 3. The protein also serves as a prognostic biomarker in colorectal carcinoma, where its expression in cancer-associated fibroblasts correlates with worse outcomes and reduced immunotherapy responses 4. Additionally, ZNF532 has been implicated in cardiovascular disease through its role in endothelial cell gene networks related to angiogenesis regulation in heart failure 5.